The money will be used to prepare for human clinical trials.
The research by
Development work for Renovacor, which employs at least five people, is done at Feldman’s lab.
___
(c)2019 The Philadelphia Inquirer
Visit The Philadelphia Inquirer at www.inquirer.com
Distributed by Tribune Content Agency, LLC.
Publicis Groupe: Overview of the share buyback program authorized by the Combined Ordinary and Extraordinary General shareholders’ Meeting of May 29, 2019
Shareholder Alert: Robbins Arroyo LLP Announces Complaint Filed Against AxoGen, Inc. (AXGN)
More Articles